Sunitinib versus sorafenib for patients with advanced renal cell carcinoma with renal impairment before the immune-oncology therapy era.
- Resource Type
- Article
- Source
- Japanese Journal of Clinical Oncology; Dec2019, Vol. 49 Issue 12, p1164-1171, 8p
- Subject
- Language
- ISSN
- 03682811